Fate Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning and welcome to the Fate Therapeutics 2021 Annual Meeting of Stockholders. I would now like to hand the call over to Scott Wolchko, CEO of Fate Therapeutics.
Good morning, everyone. I'm happy to welcome you all to the first-ever virtual meeting of the stockholders of Fate Therapeutics, Inc. We have chosen to hold this 2021 Annual Meeting of Stockholders in a virtual format for the health and well-being of our attendees.
I am Scott Wolchko, CEO of Fate Therapeutics, and I will serve as the chair of this meeting. It is just after 8 a.m. Pacific Time and in accordance with the Notice of the Meeting, I now call this meeting to order.
Maggie Wong of Goodwin Procter LLP, our outside legal counsel, will serve as secretary pro tem to record the minutes for this meeting. Before proceeding to the formal business, I would like to recognize and thank our current directors and also the officers of Fate Therapeutics who are joining us today by telephone. We also
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |